52.7 F
New York
Monday, November 28, 2022

CATEGORY

Medical & Health

Personalized Immune Therapy Shown to Extend Survival in Patients with Aggressive Brain Cancer

Denver, CO, November 22, 2022 --(PR.com)-- A Phase III clinical trial of the DCVax®-L cancer vaccine, conducted at the Sarah Cannon Research Institute at HealthONE...

Biomed Industries, Inc. Comments on Roche’s Alzheimer’s Phase III Trial

San Jose, CA, November 19, 2022 --(PR.com)-- In a news release dated November 14, 2022, Roche announced that their Alzheimer’s drug candidate, gantenerumab, did not...

Microvascular Therapeutics Receives Funds from the National Cancer Institute (NCI) for Its Brain Tumor Program

Tucson, AZ, November 18, 2022 --(PR.com)-- Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small...

Securisyn Medical awarded $249,750 Advanced Industries Early Stage Capital and Retention Grant from the Colorado Office of Economic Development and International Trade

Littleton, CO, November 18, 2022 --(PR.com)-- Securisyn Medical awarded its second Advanced Industries Early Stage Capital and Retention Grant from the Colorado Office of Economic...

HealthONE Recognized Among the 50 Most Community-Minded Companies in Denver, CO

Denver, CO, November 18, 2022 --(PR.com)-- HealthONE has been named an honoree of The Civic 50 Colorado by CSR Solutions of Colorado and Points of...

Shoals Medical Oncology Practices Combine

Huntsville, AL, November 17, 2022 --(PR.com)-- Clearview Cancer Institute (CCI) and the medical oncology division of North Alabama Cancer Center (NACC), formerly Northwest Alabama Cancer...

Averhealth Names Mark Johnson as New Chief Executive Officer

Richmond, VA, November 16, 2022 --(PR.com)-- The Board of Directors of Averhealth, a leading provider of substance use disorder (SUD) monitoring, care coordination, and related...

Latest news

- Advertisement -